3 results about "High throughput technology" patented technology

A strain of bacteria, HITLi7, based on the quantification of conserved gene abundance. T A rapid and specific detection method is involved, which uses the determination of the abundance of species-specific conserved genes to quickly detect HITLi7. T This invention addresses the challenges of complex microbial composition and the limited availability of HITLi7 strains in current bio-enhanced activated carbon processes. T The technical challenge of rapidly and specifically identifying and detecting abundance changes in indigenous bacteria presents a problem. This invention utilizes the double-positive reaction of the bispecific conserved genes gyrB and rpoB to further enhance the specificity of the detection results. The high sensitivity and accuracy based on qPCR technology further strengthen the reliability of the results. The detection method of this invention provides highly targeted results, avoiding the large amount of redundant data and complex processing procedures associated with high-throughput technologies. Compared to detection methods based on traditional bacterial morphology and physicochemical properties, it has wider applicability, higher sensitivity, and greater accuracy.

The application provides a protein chip for early warning of breast cancer and application thereof, the protein chip comprises an antigen group; the antigen group comprises antigens; antibodies corresponding to the antigens are at least one of 111 kinds of AKAP4, BRCA2, CIP2A, GIPC1, P53, SOX2, A1AT, ANGPTL4, BRAF, C1D, LRRC26 and the like; the protein chip is used for early warning and evaluation of breast cancer; steps of the early warning and evaluation include collecting serum of a to-be-tested crowd, detecting the serum by using the protein chip to obtain detection data, and then judging whether the to-be-tested crowd belongs to a low-risk, medium-risk or high-risk crowd according to a risk early warning model; the protein chip systematically detects tumor-related autoantibody risk factor signals by using a high-throughput technology, and is used for risk early warning detection of breast cancer.

This invention provides a protein chip for early warning of liver cancer and its application. The protein chip includes an antigen set; the antigen set includes antigens; the antibodies corresponding to the antigens are at least one of 61 selected from GNA11, GNAS, IDH1, MSH2, NPM1, PAX5, PTCH1, PTEN, SRSF2, Survivin, CAST, PAIP1, PRKCZ, RAD23A, RUNX1T1, SARS, TP53, APEX2, RCSD1, and AIF1; the protein chip is used for early warning assessment of liver cancer, and the early warning assessment steps include: collecting serum from the target population, using the protein chip to detect the serum to obtain detection data, and then determining whether they belong to a low-risk, medium-risk, or high-risk population based on a risk warning model; the protein chip systematically detects tumor-related autoantibody risk factor signals using high-throughput technology for early warning detection of liver cancer.